NCT02056249View on ClinicalTrials.gov

Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Hypoglycemia
Interventions
OTHER

Norepinephrine Transporter (NET) ligand

Norepinephrine Transporter (NET) ligand for iv administration during Positron Emission Tomography scan to measure changes in brain NET concentration based on insulin levels.

Trial Locations (1)

06519

PET Center, YCCI Hospital Research Unit (HRU), New Haven

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Yale University

OTHER

NCT02056249 - Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand | Biotech Hunter | Biotech Hunter